pouliot jd, dortch mj, givens g, tidwell w, hamblin se, may ak. factors associated with prolonged antibiotic use in the setting of suspected pneumonia and negative bronchoalveolar lavage cultures. hosp pharm. 2020; doi:10.1177/0018578720918548
schmidt le, hamblin se, jaynes mp, atchison l, beavers jr, dennis bm. optimization of sedative therapies leads to potential pentobarbital cost avoidance in treatment of refractory intracranial hypertension. ann pharmacother. 2020:1060028020945183. doi:10.1177/1060028020945183
labianca r, hamblin se, felbinger m, guillamondegui o, norris m, collinge c, dennis b. assessment of prophylactic antibiotic coverage in culture-positive traumatic open fractures. crit care med. 2019;47(1):852. doi: 10.1097/01.ccm.0000552495.84395.1f
schmidt l, ing a, labianca r, hamblin se, felbinger m, dennis b. assessment of prophylactic antibiotic guideline compliance in culture-positive open fractures. crit care med. 2019;47(1):851. doi: 10.1097/01.ccm.0000552494.07267.3b
smith se, hamblin se, dennis bm. effect of neuromuscular blocking agents on sedation requirements in trauma patients with an open abdomen. pharmacotherapy: the journal of human pharmacology and drug therapy. 2019;39(3):271-279. doi: 10.1002/phar.2225
gabapentin effect on opioid usage in traumatic open fracture patients
blalock s, mccluggage l, hamblin se, lindsell c, wang l, henry g, dennis b. gabapentin effect on opioid usage in traumatic open fracture patients. poster presented at: american college of clinical pharmacy annual meeting; october 26-29, 2019; new york, ny.
hamblin se, burka at. ramelteon for icu delirium prevention: is it time to melt away? crit care med. 2019;47(12):1813-1815. doi: 10.1097/ccm.0000000000004052
smith se, hamblin se, guillamondegui od, gunter ol, dennis bm. effectiveness and safety of continuous neuromuscular blockade in trauma patients with an open abdomen: a follow-up study. am j surg. 2018;216(3):414-419. doi: 10.1016/j.amjsurg.2018.04.003
labianca r, barakat o, green j, liang d, peak j, hamblin se, collins d. impact of dose-capping on time to therapeutic anti-xa levels for weight-based unfractionated heparin. crit care med. 2018;46(1):58. doi: 10.1097/01.ccm.0000528170.51450.4c
bensink j, hamblin se, jaynes m, guillamondegui o. implementation of an early vte prophylaxis protocol following surgery for traumatic spinal injury. crit care med. 2018;46(1):781. doi: 10.1097/01.ccm.0000529595.57660.1a
hammond da, holt tr, harris sa, caylor mm, kopp bj, hamblin se. perceptions of critical care pharmacists participating in a formal mentor-mentee program. am j health syst pharm. 2018;75(21):1691-1693. doi: 10.2146/ajhp180230
maguigan k, hamblin se, mulherin d, mills b, wang l, adams r. tolerance of enteral nutrition in patients with traumatic spinal cord injury receiving vasopressors. crit care med. 2018;46(1):760. doi: 10.1097/01.ccm.0000529552.43221.a4
smith s, rumbaugh k, hamblin se. vasopressin dosing protocols may result in disparate use in obese patients. jaccp: journal of the american college of clinical pharmacy. 2018;1(2):151-152. doi: 10.1002/jac5.1059
alali as, mukherjee k, mccredie va, golan e, shah ps, bardes jm, hamblin se, haut er, jackson jc, khwaja k, patel n, raj sr, wilson ld, nathens ab, patel mb. beta-blockers and traumatic brain injury: a systematic review, meta-analysis, and eastern association for the surgery of trauma guideline. ann surg. 2017;266(6):952-961. doi: 10.1097/sla.0000000000002286
dennis bm, gondek sp, guyer ra, hamblin se, gunter ol, guillamondegui od. use of an evidence-based algorithm for patients with traumatic hemothorax reduces need for additional interventions. j trauma acute care surg. 2017;82(4):728-732. doi: 10.1097/ta.0000000000001370
maguigan kl, dennis bm, hamblin se, guillamondegui od. method of hypertonic saline administration: effects on osmolality in traumatic brain injury patients. paper presented at: 11th annual academic surgical congress; february 2-4, 2016; jacksonville, fl.
dennis bm, gondek sp, hamblin se, guillamondegui og. streamlining hemothorax management: use of an evidence-based algorithm to standardize care. paper presented at: 46th annual meeting of the western trauma association; february 28-march 4, 2016; lake tahoe, ca.
maguigan k, hamblin se, dennis b, guillamondegui o. hypertonic saline and acute kidney injury in traumatic brain injury. crit care med. 2015;43(12):280. doi: 10.1097/01.ccm.0000474944.01813.23
hammond d, harris s, kopp b, hamblin se. implementation and perceptions of a critical care pharmacists’ mentor-mentee program. crit care med. 2015;43(12):166. doi: 10.1097/01.ccm.0000474487.68497.9f
kenes m, kahn s, hamblin se, reed j, guillamondegui o, miller r. effect of scheduled acetaminophen on intravenous opioid use in trauma patients. crit care med. 2014;42(12):a1609-a1610. doi: 10.1097/01.ccm.0000458534.66171.91
caylor m, hamblin se, guillamondegui o, johnson d, dennis b. efficacy of intrapleural tpa for retained hemothorax in trauma patients. crit care med. 2014;42(12):a1614. doi: 10.1097/01.ccm.0000458553.78740.64
hamblin se, bullington e, rumbaugh k, hobt-bingham t, guillamondegui o. compliance with an electronic electrolyte replacement protocol in surgical and trauma patients. crit care med. 2013;41(12):a27. doi: 10.1097/01.ccm.0000439283.76728.01
moore wp, hamblin se, pouliot jd, jenkins j, patel m, collier b. effect of antioxidant supplementation on atrial arrhythmias in trauma patients at an academic level i trauma center. crit care med. 2012;40(12):1-328. doi: 10.1097/01.ccm.0000424465.03763.3d
dortch m, pouliot jd, hamblin se, moore p, eckert m, thompson j, may a. factors associated with prolonged antibiotic use in the setting of suspected pneumonia and negative broncheoalvelor lavage cultures. crit care med. 2012;40(12):1-328. doi: 10.1097/01.ccm.0000424742.66268.f6
hamblin se, miller rs. prevention of adverse drug events and cost-savings associated with pharmd interventions in an academic level 1 trauma center: a conservative, evidence-based approach. paper presented at: 42nd annual meeting of the western trauma association; march, 2012; veil, co.
hamblin se, rumbaugh k, miller r. prevention of adverse drug events and cost savings associated with pharmd interventions in an academic level 1 trauma center: an evidence-based approach. j trauma acute care surg. 2012;73(6):1484-1490. doi: 10.1097/ta.0b013e318267cd80
dortch m, hamblin se, kauffman r, norris p, may a. combination empiric therapy for gram-negative healthcare-associated infections: adequacy of aminoglycosides versus fluoroquinolones in the setting of beta-lactam resistance. crit care med. 2010;38(12). doi: 10.1097/01.ccm.0000390903.16849.8c
woo sh, finch ck, broyles je, wan j, boswell r, hurdle a. early vs delayed enteral nutrition in critically ill medical patients. nutr clin pract. 2010;25(2):205-211. doi: 10.1177/0884533610361605
hamblin se, furmanek dl. intrapleural tissue plasminogen activator for the treatment of parapneumonic effusion. pharmacotherapy. 2010;30(8):855-862. doi: 10.1592/phco.30.8.855
hamblin se, furmanek dl. optimal methods of transitioning from intravenous nicardipine to oral antihypertensives: a pilot study. crit care med. 2009;37(12). doi: 10.1097/01.ccm.0000365439.11849.a2
hamblin se, finch cf, hurdle ac, broyles je, deaton pr, boswell rl, wan jy, nuckolls j. early versus delayed enteral nutrition in critically ill medical patients. crit care med. 2008;36(12). doi: 10.1097/01.ccm.0000341823.62097.1d